Table 1

Demographic and clinical features of the population

Patients enrolled (N=19)
Age, years (mean±SD)65±8
M/F, n11/8
IPF, n12
Other ILDs, n7
Lung function tests at baseline
Per cent of predicted FVC
Per cent of predicted SB-DLCO (mean±SD)51±19
6MWD at baseline, metres
Dropouts, n (%)2 (10.5%)
Average number of sessions attended (of 9)8
  • 6MWD, 6-min walking test distance; CTD-ILD, connective tissue disease associated interstitial lung disease; DIPNECH, diffuse idiopathic pulmonary neuroendocrine cell hyperplasia; FVC, forced vital capacity; HP, hypersensitivity pneumonitis; ILDs, interstitial lung diseases; IPF, idiopathic pulmonary fibrosis; NSIP, non-specific interstitial pneumonia; RA-ILD, rheumatoid arthritis associated interstitial lung disease; SB-DLCO, single breath diffusion lung capacity for CO.